Cargando…

Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study

BACKGROUND: Stereotactic body radiotherapy (SBRT) has proven to provide high rates of tumor control for patients with early-stage non-small cell lung cancer (NSCLC). We are reporting a multicenter experience of long-term clinical outcomes and adverse effect profiles of patients with medically inoper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yanling, Zhu, Yaoyao, Zhang, Ran, Yang, Shuangyan, Kepka, Lucyna, Viani, Gustavo Arruda, Milano, Michael T., Sio, Terence T., Sun, Xiaojiang, Wu, Hongyu, Xing, Ligang, Xu, Yaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326768/ https://www.ncbi.nlm.nih.gov/pubmed/37425405 http://dx.doi.org/10.21037/tlcr-23-180

Ejemplares similares

A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy
por: Zhang, Ran, et al.
Publicado: (2021)

Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience
por: Hijazi, Hussam, et al.
Publicado: (2016)

Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression
por: Ho, Chin-Beng, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer
por: Vargo, John A., et al.
Publicado: (2014)

Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system
por: Arruda, Gustavo Viani, et al.
Publicado: (2022)

Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
por: Liu, Yuanjun, et al.
Publicado: (2020)

Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies
por: Viani, Gustavo Arruda, et al.
Publicado: (2022)

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach
por: Comito, Tiziana, et al.
Publicado: (2014)

Stereotactic ablative radiotherapy for inoperable T1‐2N0M0 small‐cell lung cancer
por: Tang, Hui, et al.
Publicado: (2022)

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation
por: Hassanzadeh, Comron, et al.
Publicado: (2020)

Palliative radiotherapy for gastric cancer: Is there a dose relationship between bleeding response and radiotherapy?
por: Viani, Gustavo Arruda, et al.
Publicado: (2020)

A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer
por: Li, Can, et al.
Publicado: (2020)

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
por: Sun, Hui, et al.
Publicado: (2023)

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014)

High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma
por: Jang, Won Il, et al.
Publicado: (2013)

Five-Fraction Stereotactic Radiotherapy for Brain Metastases—A Retrospective Analysis
por: Layer, Julian P., et al.
Publicado: (2023)

Carbon-ion radiotherapy for inoperable endometrial carcinoma
por: Irie, Daisuke, et al.
Publicado: (2018)

Carbon ion radiotherapy for inoperable pediatric osteosarcoma
por: Mohamad, Osama, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience
por: Hobbs, Corey J., et al.
Publicado: (2017)

Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2015)

Prophylactic corticosteroid to prevent pain flare in bone metastases treated by radiotherapy
por: Viani, Gustavo Arruda, et al.
Publicado: (2021)

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy
por: Kelley, K. D., et al.
Publicado: (2015)

Long-term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients with Centrally Located Thoracic Tumors
por: Atalar, Banu, et al.
Publicado: (2020)

Impact of Carbon Ion Radiotherapy on Inoperable Bone Sarcoma
por: Shiba, Shintaro, et al.
Publicado: (2021)

A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma
por: Sun, Xiaojiang, et al.
Publicado: (2016)

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
por: Viani, Gustavo Arruda, et al.
Publicado: (2019)

Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta-analysis
por: Zhang, Xiao-fei, et al.
Publicado: (2022)

The association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer
por: Jiang, Chenxue, et al.
Publicado: (2021)

Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis
por: Lin, Qingren, et al.
Publicado: (2019)

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis
por: Cheng, Po-Lung, et al.
Publicado: (2023)

Sequential or concomitant chemotherapy with hypofractionated radiotherapy for locally advanced non-small cell lung cancer: a meta-analysis of randomized trials
por: Viani, Gustavo Arruda, et al.
Publicado: (2021)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases
por: Combs, Stephanie E., et al.
Publicado: (2018)

Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy
por: Seidensaal, Katharina, et al.
Publicado: (2022)

Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Ran, et al.
Publicado: (2022)

Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
por: Freeman, Debra E, et al.
Publicado: (2011)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients
por: Ryan, John F., et al.
Publicado: (2018)

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jlfvhttvrf5vqkpr8evrd722ss